It has been confirmed through an official announcement that Allergan is set to acquire KYTHERA Biopharmaceuticals Inc in a cash and equity transaction valued at $75 per KYTHERA share – around $2.1 billion.
KYTHERA is a biopharmaceutical company focused on developing prescription products and is best known for its lead product KYBELLA™, which has been approved as a non-surgical treatment for contouring moderate to severe submental fullness, commonly referred to as double chin.
Brent Saunders, CEO and President of Allergan, said:
“The acquisition of KYTHERA is a strategic investment that strengthens our leading global position in aesthetics and continues to position us for long-term growth”
“KYBELLA™ is an exciting new product that offers patients the first and only clinically-proven, non-surgical treatment for submental fullness (excess fat under the chin). As a leader in aesthetics, we know our customers are looking to offer their patients new options beyond traditional facial aesthetics. KYBELLA™ will do that while complementing our market leading facial aesthetics portfolio, which includes BOTOX®, JUVEDERM® XC, JUVEDERM VOLUMA® XC, LATISSE® and SKINMEDICA.”
Keith Leonard, CEO and President of KYTHERA responded, saying:
“Allergan’s world-class medical aesthetics, global footprint, history and commitment to developing leading aesthetic products makes them ideally suited to realize the maximum commercial potential of KYBELLA™”
Double Chin Treatment
Submental fullness is a common condition, which has been estimated by the American Society for Dermatologic Surgery to affect 67% of consumers.
The development of a double chin can lend the face an older and heavier look.
Reducing the fat beneath the chin, tackling double chin and contouring the area beneath the jawline.
KYBELLA™ is not yet available in the UK, but is expected later in 2015.
SkinViva Training and Allergan
SkinViva Training work closely with Allergan in the UK and are one of 30 companies to be part of Allergan’s elite training academy, as well as working together with Allergan representatives to build the consumer business SkinViva.
We will therefore bring you further news of this exciting product as it becomes available.
Cosmetic Treatments Training
Botox and Fillers Courses, Manchester
SkinViva Training Academy offers a comprehensive range of botox and fillers training courses designed for medical professionals such as suitably qualified and registered medical professionals who wish to learn and build on their skills in delivering these procedures.
SkinViva Training was established by Dr Tim Pearce MBChB BSc (Hons) MRCGP. The SkinViva Training team upholds high standards of clinical training providing a combination of fully-supervised practical experience together with essential theory.
For further information, to discuss which course is right for you, to enquire about availability or to book a training course please call 0161 850 2491, or email firstname.lastname@example.org.